We are live on ! Find out more
BC

Broadwood Capital Portfolio holdings

AUM $1.42B
1-Year Est. Return 34.72%
This Fund
S&P 500
This Quarter Est. Return
+21.79%
1 Year Est. Return
+34.72%
3 Year Est. Return
+45.97%
5 Year Est. Return
+44.27%
10 Year Est. Return
+866.96%
AUM
$584M
AUM Growth
+$66.9M
Cap. Flow
-$4.12M
Cap. Flow %
-0.71%
Top 10 Hldgs %
100%
Holding
10
New
–
Increased
1
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
IMDX
Insight Molecular Diagnostics
IMDX
+$6.21M

Top Sells

Rank Stock Value
1
IMPR
IMPRIVATA, INC COM
IMPR
+$10.3M

Sector Composition

Rank Sector Weight
1 Healthcare 42.88%
2 Consumer Staples 40.17%
3 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MNST icon
1
Monster Beverage
MNST
$94.3B
$235M 40.17%
9,594,816
– –
STAA icon
2
STAAR Surgical
STAA
$1.21B
$102M 17.46%
10,855,179
– –
LCTX icon
3
Lineage Cell Therapeutics
LCTX
$269M
$97.1M 16.61%
28,457,308
– –
IWM icon
4
iShares Russell 2000 ETF
IWM
$79.8B
$52.2M 8.93%
420,000
– –
CYNO
5
DELISTED
Cynosure, Inc. Class A
CYNO
$46.7M 7.99%
916,975
– –
MNK
6
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$22.5M 3.85%
322,411
– –
AST
7
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$15.7M 2.68%
3,699,848
– –
IMDX
8
Insight Molecular Diagnostics
IMDX
$150M
$13.3M 2.27%
131,584
+76,923
+141% +$6.21M
AST.WS
9
DELISTED
Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017)
AST.WS
$171K 0.03%
328,205
– –
IMPR
10
DELISTED
IMPRIVATA, INC COM
IMPR
– –
-737,911
Closed -$10.3M

Similar funds

PTC
Philadelphia Trust Company Philadelphia, Pennsylvania $1.42B AUM 43.77% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
CBA
Coastal Bridge Advisors Westport, Connecticut $1.41B AUM 24.15% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
EWS
Evergreen Wealth Solutions Williamsport, Pennsylvania $1.41B AUM 18.71% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.42B AUM 41.03% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return
PPC
Park Presidio Capital San Francisco, California $1.43B AUM 21.33% 1-Year Est. Return

Broadwood Capital's Q3 2016 Portfolio in Review

As of Q3 2016, Broadwood Capital held 10 positions worth $584M, up 13% from $517M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Broadwood Capital's Q3 2016 filing shows 1 increased and 1 closed positions. The largest sale was IMPRIVATA, INC COM, an estimated $10.3M.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, up from 30% a quarter earlier, followed by Consumer Staples and Technology.

  • Broadwood Capital added most to Insight Molecular Diagnostics in Q3 2016, an estimated $6.21M increase.
  • Broadwood Capital fully exited IMPRIVATA, INC COM in Q3 2016, selling an estimated $10.3M.
  • Broadwood Capital's ten largest holdings make up 100% of its $584M portfolio in Q3 2016.
  • Broadwood Capital opened 0 new positions and closed 1 in Q3 2016.
  • Broadwood Capital's portfolio value rose 13% quarter-over-quarter to $584M.

Based on Broadwood Capital's 13F filing for Q3 2016, filed 14 Nov 2016.